Vendor products
Assessment of relevant quantitative data from tumors by histology is a cornerstone of cancer research and diagnostics. Today it is a challenge to understand, define and quantify tumor heterogeneity in a way that has practical utility for...
Two great career opportunities are now available with Visiopharm in the United States to expand our dedicated, North American team. The first position is for a Regional Director of Sales, specializing in the Biopharmaceutical market and based...
PathXL has today launched a next generation tablet version for PathXL Tutor that delivers a broad range of new capabilities to the marketplace. This new product was developed in a close working partnership with the University of...
Thanks to everyone who participated in our recent draw for a 6 month license of microDimensions Voloom! The winner of a free license for Voloom, the fastest and most versatile software for histology 3D reconstruction, has been drawn. Among all...
Date: Thursday, January 29th Time: 10am - 11am CST | 4pm - 5pm GMT Prof. Peter Hamilton | VP Research and Development, PathXL Eileen Regan | Head of Account Management and Pre-Sales Empower your...
Applied Spectral Imaging receives FDA Clearance for GenASIs™ HiPath...
- Anatomic Pathology
- Business
- Clinical Laboratories
- Device Manufacturers
- Digital Pathology News
- Genetics
- Government
- Histology
- Image Analysis
- Informatics
- International
- Laboratory Compliance
- Laboratory Management & Operations
- Marketing
- Microscopy
- Pathology News
- Standards and Guidelines
- Vendor products
- Web/Tech
Carlsbad, CA. - January 21, 2015 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis...
































